With a background in finance, energy, law, and healthcare, she forges strategic alliances with hospitals, insurers, and nonprofits to advance medical innovation and health equity on a global scale. Today, she brings her vision for a future where every child born with a cleft condition has access to life-changing care.
Madame founded Mu’id Mecca Medical Corporation and led the development of a patented non-invasive medical headwear device that provides a gentle and effective alternative to traditional taping methods used in pre-surgical orthodontic care for infants with cleft conditions. The device improves patient outcomes by reducing more corrective surgery outcomes and increasing treatment adherence, resulting in less distress for infants and greater ease of use for families. Through the Faisal Foundation, Madame has supported broader access to cleft surgeries by providing scholarships and logistical support for patients in underserved regions.
Among her distinguished accomplishments, she successfully completed advanced legal training through the WIPO–Harvard Law PatentX program, with a focus on Patent Law, Innovation, and Global Health Crisis. This expertise positions her to support diplomatic initiatives and collaborate with international governments and NGOs on global policy and innovation matters. She also holds a Safety Standards certification from the International Atomic Energy Agency (IAEA), validating her expertise in risk mitigation and regulatory standards. She has also been featured in professional forums focused on women in STEM, global health equity, and legal innovation.

This recognition underscores Madame E’s contributions to medical innovation, health equity, and patient-centered care, highlighting her efforts to improve outcomes for infants with cleft conditions and expand access to treatment globally.
The Health 2.0 Conference is a three-day wellness conference that brings together researchers, policymakers, and healthcare providers committed to advancing global health. With upcoming editions in Las Vegas, Singapore, and Dubai, the conference addresses critical themes including nutrition, pharmaceutical and therapeutic innovation, cancer care and research, diversity, equity & inclusion in healthcare, and digital therapeutics, among others. The conference offers keynote sessions, panel discussions, and networking opportunities for healthcare professionals to exchange insights and explore emerging solutions. For more information about the Health 2.0 Conference, please visit www.health2conf.com.